Document Detail

Integrated Metabolomic Profiling of Hepatocellular Carcinoma in Hepatitis C Cirrhosis through GC/MS and UPLC/MS-MS.
MedLine Citation:
PMID:  24661807     Owner:  NLM     Status:  Publisher    
BACKGROUND: The metabolic pathway disturbances associated with hepatocellular carcinoma (HCC) remain unsatisfactorily characterized. Determination of the metabolic alterations associated with the presence of HCC can improve our understanding of the pathophysiology of this cancer and may provide opportunities for improved disease monitoring of patients at risk for HCC development.
AIM: To characterize the global metabolic alterations associated with HCC arising from hepatitis C (HCV)-associated cirrhosis using an integrated non-targeted metabolomics methodology employing both gas chromatography/mass spectrometry (GC/MS) and ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry (UPLC/MS-MS).
METHODS: The global serum metabolomes of 30 HCC patients, 27 hepatitis C-cirrhosis disease controls, and 30 healthy volunteers were characterized using a metabolomics approach that combined two metabolomics platforms, GC/MS and UPLC/MS-MS. Random forest, multivariate statistics, and receiver operator characteristic analysis were performed to identify the most significantly altered metabolites in HCC patients versus HCV-cirrhosis controls and which therefore exhibited a close association with the presence of HCC.
RESULTS: Elevated 12-hydroxyeicosatetraenoic acid (12-HETE), 15-HETE, sphingosine, γ-glutamyl oxidative stress-associated metabolites, xanthine, amino acids serine, glycine and aspartate, and acylcarnitines were strongly associated with the presence of HCC. Elevations in bile acids and dicarboxylic acids were highly correlated with cirrhosis.
CONCLUSIONS: Integrated metabolomic profiling through GC/MS and UPLC/MS-MS identified global metabolic disturbances in HCC and HCV-cirrhosis. Aberrant amino acid biosynthesis, cell turnover regulation, reactive oxygen species neutralization, and eicosanoid pathways may be hallmarks of HCC. Aberrant dicarboxylic acid metabolism, enhanced bile acid metabolism, and elevations in fibrinogen cleavage peptides may be signatures of cirrhosis. This article is protected by copyright. All rights reserved.
Asem I Fitian; David R Nelson; Chen Liu; Yiling Xu; Miguel Ararat; Roniel Cabrera
Related Documents :
17536817 - Cytogenetic effects of grape extracts (vitis vinifera) and polyphenols on mitomycin c-i...
23790937 - Enzymatic browning and after-cooking darkening of jerusalem artichoke tubers (helianthu...
24055967 - Thermal decomposition of lignocellulosic biomass in the presence of acid catalysts.
24130027 - Identification and quantitation of new glutamic acid derivatives in soy sauce by uplc/m...
2592567 - Identification of a satellite fatty acid ethyl ester synthase from human myocardium as ...
19337627 - 24-hour ambulatory ph-metry in patients with refractory heartburn: a prospective study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-24
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  -     ISSN:  1478-3231     ISO Abbreviation:  Liver Int.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
This article is protected by copyright. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nosocomial tuberculosis exposures at a tertiary care hospital: A root cause analysis.
Next Document:  Frequency of eprinomectin resistance in gastrointestinal nematodes of goats in canton Berne, Switzer...